Skip to main navigation Skip to search Skip to main content

Interferon-induced pulmonary sarcoidosis

  • Raymond Farah
  • , R. Farah
  • , N. Makhoul

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

A further new case of sarcoidosis associated with the use of interferon (IFN) in the classical treatment of chronic hepatitis C (CHC) is reported. During the last two years, more than 20 cases of interferon-induced sarcoidosis have been described in the literature and about half of these cases have involved CHC. Therefore this disorder appears more common than originally thought two years ago, possibly due to the more frequent use of interferon therapy and an improvement in the methods of diagnosis.

Original languageEnglish
Pages (from-to)441-443
Number of pages3
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Volume43
Issue number9
DOIs
StatePublished - Sep 2005
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chronic hepatitis
  • Granuloma
  • Interferon
  • Sarcoidosis

Fingerprint

Dive into the research topics of 'Interferon-induced pulmonary sarcoidosis'. Together they form a unique fingerprint.

Cite this